Indegene's Q3 FY 2025-26 Quarterly Results
- 30 Jan 2026
Result Summary
- Indegene Ltd reported a 16.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 26.8%.
- Its expenses for the quarter were up by 19.7% QoQ and 35.1% YoY.
- The net profit increased 0.8% QoQ and decreased 6.2% YoY.
- The earnings per share (EPS) of Indegene Ltd stood at 4.26 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 961.50 | 823.90 | 758.10 | 16.7% | 26.8% |
Total Expenses | 826.80 | 690.80 | 611.80 | 19.7% | 35.1% |
Profit Before Tax | 134.70 | 133.10 | 146.30 | 1.2% | -7.9% |
Tax | 31.80 | 31.00 | 36.60 | 2.6% | -13.1% |
Profit After Tax | 102.90 | 102.10 | 109.70 | 0.8% | -6.2% |
Earnings Per Share | 4.26 | 4.23 | 4.55 | 0.7% | -6.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Indegene Ltd is a prominent player in the healthcare and pharmaceutical industry, known for providing a range of services including healthcare solutions, technology platforms, and consulting services. The company specializes in offering solutions that enhance the effectiveness of healthcare delivery and pharmaceutical commercialization. Indegene's clientele primarily includes pharmaceutical companies, healthcare providers, and life sciences organizations. As of the latest updates available, Indegene has been focusing on expanding its digital transformation initiatives and enhancing its technological capabilities to better serve its clients. However, specific recent developments or strategic shifts were not provided in the data, and further insights into these areas are not available at this time.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Indegene Ltd reported total income of ₹961.50 crores. This marks a substantial increase from the previous quarter (Q2FY26), where the total income was ₹823.90 crores, reflecting a quarter-over-quarter (QoQ) growth of 16.7%. Moreover, when compared to the same quarter in the previous fiscal year (Q3FY25), where the total income was ₹758.10 crores, there is a significant year-over-year (YoY) growth of 26.8%. This growth in total income indicates a robust revenue performance over the periods compared, and highlights the company's capacity to generate increasing income.
Profitability
Indegene Ltd's profitability metrics for Q3FY26 reveal a mixed performance. The Profit Before Tax (PBT) for the quarter stood at ₹134.70 crores, showing a slight QoQ increase of 1.2% from ₹133.10 crores in Q2FY26. However, PBT decreased by 7.9% YoY from ₹146.30 crores in Q3FY25. The company's Profit After Tax (PAT) for Q3FY26 was ₹102.90 crores, showing a marginal QoQ improvement of 0.8% from ₹102.10 crores in Q2FY26, but a YoY decline of 6.2% from ₹109.70 crores in Q3FY25. The Earnings Per Share (EPS) for the quarter was ₹4.26, a slight QoQ increase of 0.7% from ₹4.23 in Q2FY26, yet a decrease of 6.4% YoY from ₹4.55 in Q3FY25. These figures indicate a stable performance in terms of profitability, albeit with some declines when compared year-over-year.
Operating Metrics
The total expenses for Indegene Ltd in Q3FY26 were ₹826.80 crores, which represents a 19.7% increase from ₹690.80 crores in Q2FY26, and a 35.1% increase from ₹611.80 crores in Q3FY25. The increase in expenses outpaced the growth in total income on both a QoQ and YoY basis. The taxation for the quarter was ₹31.80 crores, showing a 2.6% increase QoQ from ₹31.00 crores in Q2FY26 and a 13.1% decrease YoY from ₹36.60 crores in Q3FY25. The financial ratios and other operating metrics such as P/E ratio, debt-to-equity ratio, and current ratio were not provided in the available data, and hence, are not calculated here. The trends in expenses and taxation are important for understanding the operational efficiency and cost management of the company.